Axon Enterprise (NASDAQ:AXON) Announces Quarterly Earnings Results, Misses Estimates By $0.48 EPS

Axon Enterprise (NASDAQ:AXON) issued its quarterly earnings data on Tuesday. The biotechnology company reported $0.89 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.48), Zacks reports. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. Axon Enterprise updated its FY 2025 guidance to EPS and its FY 2025 guidance to EPS.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON traded down $3.08 during trading hours on Tuesday, reaching $496.65. 1,295,552 shares of the stock were exchanged, compared to its average volume of 743,113. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The firm has a market capitalization of $37.87 billion, a price-to-earnings ratio of 128.33, a P/E/G ratio of 5.17 and a beta of 1.05. The stock’s fifty day simple moving average is $616.95 and its 200 day simple moving average is $520.78. Axon Enterprise has a 52 week low of $265.32 and a 52 week high of $715.99.

Analyst Ratings Changes

AXON has been the subject of several research analyst reports. TD Cowen initiated coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target for the company. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Craig Hallum cut shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price objective on the stock. in a research report on Thursday, February 20th. Needham & Company LLC boosted their price target on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. Finally, The Goldman Sachs Group upped their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $561.31.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. The trade was a 6.10 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Jeffrey C. Kunins sold 2,304 shares of the company’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total value of $1,508,636.16. Following the sale, the insider now owns 128,542 shares of the company’s stock, valued at approximately $84,168,016.18. The trade was a 1.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 8,711 shares of company stock worth $5,631,561. Corporate insiders own 5.70% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.